Hosted on MSN1mon
Beacon secures $170m to advance ophthalmic gene therapiesBeacon Therapeutics has raised $170m in a Series B funding round to accelerate the development of its lead asset AGTC-501, for X-linked retinitis pigmentosa (XLRP). The financing round was led by ...
Bangladesh’s pharmaceutical industry has undergone ... access to life-saving drugs,” says Monjurul Alam, CEO of Beacon Medicare Ltd, adding that it was his vision that led to Beacon now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback